Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11519006 Methods and compositions for the activation of gamma-delta T-cells

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

American Gene Technologies

Current Assignee

American Gene Technologies

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

December 6, 2022

Patent Application Number

16563738

Date Filed

September 6, 2019

Patent Citations

US Patent 10233464 HIV pre-immunization and immunotherapy

US Patent 10428350 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10772905 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10767183 Combination vectors and methods for treating cancer

US Patent 10023880 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10036038 HIV pre-immunization and immunotherapy

US Patent 10036040 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10137144 Methods and compositions for the activation of gamma-delta T-cells

...

Patent Primary Examiner

The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11519006 Methods and compositions for the activation of gamma-delta T-cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool